Identification of Mycobacterium leprae and Mycobacterium lepromatosis in Formalin-Fixed and Paraffin-Embedded Skin Samples from Mexico
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The causative agents of leprosy are the well-known Mycobacterium leprae and the newly discovered Mycobacterium lepromatosis. This agent was found in 2008, and it was found to be the cause of diffuse lepromatous leprosy in two Mexican patients. Objective: The objective of this work was to determine if M. leprae and M. lepromatosis were present in formalin-fixed and paraffin- embedded skin samples from cases from different regions in Mexico. Methods: A total of 41 skin samples were obtained from 11 states of Mexico. All patients’ samples were diagnosed by clinical and histopathological analyses. Total DNA was isolated using a Qiagen-DNeasy blood and tissue kit and molecular identification was achieved by two semi-nested polymerase chain reactions. Results: The 41 patient included 33 samples from men and 8 samples from women; 29 samples were polymerase chain reaction (PCR)-positive to Mycobacterium and 12 samples were PCR-negative. From those 29 samples, 13 were PCR-positive to M. leprae, 8 to M. lepromatosis and 8 were positive to both species. The histopathological diagnosis included; Nodular lepromatous leprosy (NLL); Diffuse lepromatous leprosy (DLL); and Borderline leprosy (BL). The 29 PCR-positive samples were classified as follow: 14 NLL, 4 DLL, and 11 BL. In the 12 samples negative to Mycobacterium, 7 showed the NLL, 2 DLL and 3 BL. Conclusion: These findings add evidence to the M. leprae and M. lepromatous distribution, clinical forms and participation of dual infections in Mexico.
Abstract
Background: The causative agents of leprosy are the well-known Mycobacterium leprae and the newly discovered Mycobacterium lepromatosis. This agent was found in 2008, and it was found to be the cause of diffuse lepromatous leprosy in two Mexican patients. Objective: The objective of this work was to determine if M. leprae and M. lepromatosis were present in formalin-fixed and paraffin- embedded skin samples from cases from different regions in Mexico. Methods: A total of 41 skin samples were obtained from 11 states of Mexico. All patients’ samples were diagnosed by clinical and histopathological analyses. Total DNA was isolated using a Qiagen-DNeasy blood and tissue kit and molecular identification was achieved by two semi-nested polymerase chain reactions. Results: The 41 patient included 33 samples from men and 8 samples from women; 29 samples were polymerase chain reaction (PCR)-positive to Mycobacterium and 12 samples were PCR-negative. From those 29 samples, 13 were PCR-positive to M. leprae, 8 to M. lepromatosis and 8 were positive to both species. The histopathological diagnosis included; Nodular lepromatous leprosy (NLL); Diffuse lepromatous leprosy (DLL); and Borderline leprosy (BL). The 29 PCR-positive samples were classified as follow: 14 NLL, 4 DLL, and 11 BL. In the 12 samples negative to Mycobacterium, 7 showed the NLL, 2 DLL and 3 BL. Conclusion: These findings add evidence to the M. leprae and M. lepromatous distribution, clinical forms and participation of dual infections in Mexico.
참고문헌 (21)
- Lupi O, "Tropical dermatology: bacterial tropical diseases", J Am Acad Dermatol, 54, pp.559~578 (2006)[DOI]
- Han XY, "A new mycobacterium species causing diffuse lepromatous leprosy", Am J Clin Pathol, 130, pp.856~864 (2008)[DOI]
- World Health Organization, "Global leprosy update, 2015: time for action, accountability and inclusion", Wkly Epidemiol Rec, 91, pp.405~420 (2016)
- [URL]
- Han XY, "Comparative sequence analysis of mycobacterium leprae and the new leprosy-causing mycobacterium lepromatosis", J Bacteriol, 191, pp.6067~6074 (2009)[DOI]
- Han XY, "The leprosy agents mycobacterium lepromatosis and mycobacterium leprae in Mexico", Int J Dermatol, 51, pp.952~959 (2012)[DOI]
- Han XY, "Draft genome sequence of new leprosy agent mycobacterium lepromatosis", Genome Announc, 3, pp.e00513~e00515 (2015)
- Singh P, "Insight into the evolution and origin of leprosy bacilli from the genome sequence of mycobacterium lepromatosis", Proc Natl Acad Sci U S A, 112, pp.4459~4464 (2015)[DOI]
- Cox RA, "The 16S ribosomal RNA of mycobacterium leprae contains a unique sequence which can be used for identification by the polymerase chain reaction", J Med Microbiol, 35, pp.284~290 (1991)[DOI]
- Pfaltzgraff RE, "What is the actual male", female sex ratio in leprosy patients?, 2003, pp.74, 180~181
- Atoche C, "Leprosy in Yucatan, retrospective clinical study of 63 years (1950-2013)", Salud Publica Mex, 57, pp.191~192 (2015)
- Han XY, "Analysis of the leprosy agents mycobacterium leprae and mycobacterium lepromatosis in four countries", Am J Clin Pathol, 142, pp.524~532 (2014)[DOI]
- Vera-Cabrera L, "Case of diffuse lepromatous leprosy associated with "mycobacterium lepromatosis"", J Clin Microbiol, 49, pp.4366~4368 (2011)[DOI]
- Vera-Cabrera L, "Mycobacterium lepromatosis infections in Nuevo Leon, Mexico", J Clin Microbiol, 53, pp.1945~1946 (2015)[DOI]
- Han XY, "Identification of the leprosy agent mycobacterium lepromatosis in Singapore", J Drugs Dermatol, 11, pp.168~172 (2012)
- Jessamine PG, "Leprosy-like illness in a patient with mycobacterium lepromatosis from Ontario, Canada", J Drugs Dermatol, 11, pp.229~233 (2012)
- Han XY, "Detection of the leprosy agent mycobacterium lepromatosis in South America and Europe", Am J Trop Med Hyg, 96, pp.260~ (2017)[DOI]
- Sotiriou MC, "Two cases of leprosy in siblings caused by mycobacterium lepromatosis and review of the literature", Am J Trop Med Hyg, 95, pp.522~527 (2016)[DOI]
- Virk A, "Mycobacterium lepromatosis lepromatous leprosy in US citizen who traveled to disease-endemic areas", Emerg Infect Dis, 23, pp.1864~1866 (2017)[DOI]
- Gillis TP, "What is the evidence that the putative mycobacterium lepromatosis species causes diffuse lepromatous leprosy?", Lep Rev, 82, pp.205~209 (2011)
- Herath S, "Lucio's phenomenon, an uncommon occurrence among leprosy patients in Sri Lanka", BMC Res Notes, 8, pp.672~ (2015)[DOI]